Cov neeg tsim tshuaj tiv thaiv Covid-19 ntsib kev sib tw tshiab raws li GlaxoSmithKline thiab Sanofi Npaj nkag mus rau lub nplhaib

Raws li Covid-19 cov neeg mob tshiab poob, kev lag luam tshuaj tiv thaiv kab mob tom qab nthuav dav ntxiv. Hnub Wednesday, GlaxoSmithKline thiab Sanofi, ob tus neeg tsim tshuaj tiv thaiv loj tshaj plaws hauv ntiaj teb, tau hais tias lawv yuav xa cov tshuaj tiv thaiv Covid rau Asmeskas thiab European kev pom zoo. Nyob rau lub caij nplooj ntoo hlav xyoo 2020, ntau tus xav tias khub niam txiv cov tshuaj tiv thaiv yuav ua ntej tawm ntawm qhov rooj. Tab sis thaum ntxov tau poob siab. Tam sim no lawv tab tom tsom mus rau lawv cov tshuaj tiv thaiv ntau ntawm lub khw txhawb nqa, ceeb toom tias cov neeg tau txais cov tshuaj tiv thaiv kab mob sib txawv pom cov tshuaj tiv thaiv kab mob tsis zoo nce 18- txog 30-fold thaum txhawb nqa lawv cov tshuaj tiv thaiv.

Kev pom zoo…

Tau qhov twg los: https://www.barrons.com/articles/covid-19-booster-glaxosmithkline-sanofi-51645839555?siteid=yhoof2&yptr=yahoo